Vaccine Care StocksVaccine-Med

Vaccine-Med

piIndication.tooltipPi0

Vaccine Care Stocks

Vaccine Care Stocks
United Kingdom
7
Risk

Vaccines have saved millions of lives for decades and protect against infectious diseases. With the recent Covid-19 pandemic, vaccine development became one of the hottest topics globally, as efforts to... Show More
28,237
Followers
840
-10userSocialWidget.week
Investors
10 Investors  Last 7 days

Top Traded

Novavax Inc
NVAX
3.69 (5.00%)
S
77.29
B
77.55
Vaxart Inc
VXRT
0.27 (6.05%)
S
4.70
B
4.73
Moderna Inc
MRNA
21.24 (14.34%)
S
169.19
B
169.54
View more

Similar Traders

View More
Pinned Post
Vaccine Care Stocks
𝗦𝗮𝗻𝗼𝗳𝗶 𝘁𝗼 𝗦𝗽𝗲𝗻𝗱 €𝟵𝟯𝟱 𝗠𝗶𝗹𝗹𝗶𝗼𝗻 𝗼𝗻 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗶𝗻𝗴 𝗺𝗥𝗡𝗔 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗶𝗻 𝗙𝗿𝗮𝗻𝗰𝗲 French drugmaker $SAN.PA (Sanofi) plans to invest € 935 Million over the next few years to develop messenger RNA vaccines in France, a push into the technology behind some of the... Show More
User Feed
Top
Vaccine Care Stocks
Dear Investors, Here is your monthly update for February 2022. The month of February was dominated by rising geopolitical tensions in eastern Europe as Russia launched an invasion into Ukraine. Markets continued to trade cautiously throughout the month while commodity prices rose. Cryptocurrencies... Show More
Like CommentShare
1 reply
null
.
Vaccine Care Stocks
Dear Investors, Here is your monthly update for January 2022. The new year started on the back foot as the ongoing Covid-19 pandemic, rising bond yields, geo-political tensions and inflation concerns caused a broad-based decline in asset prices,with the tech-heavy Nasdaq Index even falling into correction... Show More
Vaccine Care Stocks
𝗣𝗳𝗶𝘇𝗲𝗿 𝗮𝘀𝗸𝘀 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 𝗳𝗼𝗿 𝗶𝘁𝘀 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝘁𝗼 𝗸𝗶𝗱𝘀 𝘂𝗻𝗱𝗲𝗿 𝟱 / 𝗠𝗼𝗱𝗲𝗿𝗻𝗮’𝘀 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗿𝗲𝗰𝗲𝗶𝘃𝗲𝘀 𝗳𝘂𝗹𝗹 𝗙𝗗𝗔 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹. Pharma company $PFE (Pfizer) and its biotech partner $BNTX (BioNTech SE) filled a submission... Show More
Like CommentShare
1 reply
1 reply
null
.
Vaccine Care Stocks
𝗣𝗳𝗶𝘇𝗲𝗿 𝗮𝗻𝗱 𝗕𝗶𝗼𝗡𝗧𝗲𝗰𝗵 𝗯𝗲𝗴𝗶𝗻 𝗮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘁𝗿𝗶𝗮𝗹 𝗳𝗼𝗿 𝗮𝗻 𝗢𝗺𝗶𝗰𝗿𝗼𝗻-𝘀𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝘃𝗮𝗰𝗰𝗶𝗻𝗲. Pharma giant $PFE (Pfizer) and its biotech partner $BNTX (BioNTech SE) announced they have begun a clinical trial to evaluate the safety and effectiveness of a vaccine... Show More
Like CommentShare
null
.